StockNews.com began coverage on shares of Sorrento Therapeutics (NASDAQ:SRNE – Free Report) in a report published on Thursday morning. The firm issued a hold rating on the biopharmaceutical company’s stock. Sorrento Therapeutics Stock Performance NASDAQ:SRNE opened at $0.01 on Thursday. Sorrento Therapeutics has a one year low of $0.00 and a one year high of […]